profit from every $100 of sales.
$0$100
Pulsenmore Ltd. Ordinary Shares
$1.38-6.12% today
-81.3% since Jan 21, 26
1-year low $1.381-year high $7.36
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Pulsenmore Ltd. Ordinary Shares sold, what it kept, and what it did with the cash.
Sales went from ₪10.8 million in 2022 to ₪40.0 million in 2025, with -₪15.9 million of profit last year.
SalesProfit
Pulsenmore Ltd. Ordinary Shares vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares | No profit yet | ||
 Boston Scientific | 22.2× · Fair price | ||
 Koninklijke Philips | 30.1× · Expensive | ||
 Steris | 32.8× · Expensive | ||
 Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Pulsenmore Ltd. Ordinary Shares's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of ILS | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 11 | 6 | 10 | 40 | |
| 5 | 2 | 4 | 34 | |
| -46 | -56 | -42 | -12 | |
| -21 | -55 | -33 | -13 | |
| -22 | -59 | -37 | -16 | |
| -3.68 | -9.12 | -5.76 | -2.46 | |
| 47.4% | 35.6% | 37.0% | 84.2% | |
| -427.2% | -898.3% | -437.0% | -30.4% | |
| -204.5% | -946.5% | -380.3% | -39.6% |
Balance sheet
| In millions of ILS | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 236 | 180 | 142 | 102 |
| Cash | 15 | 24 | 41 | 22 |
| Total debt | 4 | 3 | 2 | 2 |
| Total liabilities | 49 | 48 | 45 | 19 |
| 188 | 132 | 97 | 83 | |
| 6 | 6 | 6 | 6 | |
| -9.0% | -33.7% | -29.0% | -14.5% | |
| -11.8% | -44.3% | -37.9% | -19.1% |
Cash flow
| In millions of ILS | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -28 | -50 | -41 | -33 | |
| 5 | 4 | 1 | 0 | |
| -32 | -54 | -42 | -33 | |
| Dividends paid | 0 | 0 | 0 | 0 |
| – | – | – | – | |
| 5 | 3 | 1 | 1 |
Valuation
- –
- –
- –
- 1.0×
- 0.7×
- –
- –
- -114.6%
- -55.0%
- 0.0%
Profitability
- 84.2%
- -30.4%
- -39.6%
- -31.8%
- -13.1%
- -25.2%
- -30.2%
- -15.6%
- -13.3%
- 43.3%
Growth
- +54.7%
- –
- −250.7%
- –
- +5.8%
Financial health
- -1.6×
- 0.02
- 1.5%
- -38.6×
- 7.88
- 7.24
- 0.39
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 22%of 952
Bottom 9%of 884
Top 11%of 886
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
68Pass
Philip Fisher
53No pass
Peter Lynch
73Pass
Joel Greenblatt
2No pass
Charlie Munger
41No pass
Terry Smith
51No pass
Questions about Pulsenmore Ltd. Ordinary Shares
Is Pulsenmore Ltd. Ordinary Shares a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Pulsenmore Ltd. Ordinary Shares AI analysis
What does Pulsenmore Ltd. Ordinary Shares do?
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. It is in Medical - Devices.
Does Pulsenmore Ltd. Ordinary Shares pay a dividend?
No. Pulsenmore Ltd. Ordinary Shares does not pay a dividend at the moment.
Is Pulsenmore Ltd. Ordinary Shares stock halal?
No. Pulsenmore Ltd. Ordinary Shares does not pass our halal screen: its cash and confirmed interest-bearing investments are 75% of its market value, at or above the 33% limit. How we check
Who are Pulsenmore Ltd. Ordinary Shares's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Pulsenmore Ltd. Ordinary Shares's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.